Siemens Respiratory Test Kit Clinitest® At-Home OTC COVID-19 Test 800 Tests CLIA Waived - Case of 200 - 11561909-CS
Siemens Respiratory Test Kit Clinitest® At-Home OTC COVID-19 Test 800 Tests CLIA Waived - Case of 200 - 11561909-CS
Regular price
$7,167.99
Sale price
$7,167.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver: Jan23 - Jan26
Free Shipping & Returns: On orders above $79
Estimated deliver 5-7 days
Siemens Respiratory Test Kit Clinitest® At-Home OTC COVID-19 Test 800 Tests CLIA Waived
| Item Id | 1211174 |
| MF Id# | 11561909 |
| Brand | Clinitest® |
| Manufacturer | Siemens |
| Country of Origin | China |
| Application | Respiratory Test Kit |
| CLIA Classified | CLIA Waived |
| Contents 1 | Each Kit has: (4) Test Devices, (4) Sterile Swabs, (4) Extraction Tubes with Buffers and Tips, Instructions for Use |
| Is_Active_Vendor | Y |
| Is_DSCSA | N |
| Is_Discontinued | N |
| Is_Medical_Device | N |
| Lot_Tracking_Flag | N |
| Number of Tests | 800 Tests |
| On_Allocation | N |
| Purchase Program Type | Standard Purchase |
| Reading Type | Visual Read |
| Sample Type | Nasal Swab Sample |
| Specialty | Immunoassay |
| Supplier_ID | 3849247 |
| Test Format | Cassette Format |
| Test Kit Type | Rapid |
| Test Method | Lateral Flow Chromatographic Immunoassay |
| Test Name | At-Home OTC COVID-19 Test |
| Test Type | Antigen Detection |
| Time to Results | 15 Minute Results |
| UNSPSC Code | 41116144 |
Features
- The CLINITEST® Rapid COVID-19 Antigen Self-Test is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
- The CLINITEST® At-Home OTC COVID-19 Test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2
- This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older with symptoms of COVID-19 within the first 7 days of symptom onset
- This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset
- Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in anterior nasal (nares) swabs during the acute phase of infection
- Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Individuals who test positive with CLINITEST® Rapid COVID-19 Antigen Self-Test should self-isolate and seek follow-up care with their physician or healthcare provider as additional testing may be necessary
- Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
- Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
- Individuals should provide all results obtained with this product to their healthcare provider for public health reporting
- With the CLINITEST® Rapid COVID-19 Antigen Self-Test, you can expect accurate and reliable results in just 15 minutes
- 200 4pk kits in a case or 800 total tests